C57BL/6-Epm2aem1Cwor/Cnbc

Status

Available to order

EMMA IDEM:15645
Citation informationRRID:IMSR_EM:15645 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6-Epm2aem1Cwor/Cnbc
Alternative nameEpm2a-R240X
Strain typeEndonuclease-mediated
Allele/Transgene symbolEpm2aem1Cwor
Gene/Transgene symbolEpm2a

Information from provider

ProviderMarina P. Sánchez García
Provider affiliationNeurology Laboratory, Health Research Institute- Fundación Jiménez Díaz
Additional ownerMatthew S. Gentry, Ph.D., Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA
Genetic informationThe Epm2a-R240X mouse model was created using CRISPR/Cas9 technology. These mice express the R240X mutation (arginine to termination codon) in the Epm2a gene (epilepsy, progressive myoclonic epilepsy, type 2), equivalent to the human R241X mutation.
Phenotypic informationHomozygous:
Mice homozygous for the mutation develop most of the alterations reported in patients with Lafora disease, including the presence of Lafora bodies, neurodegeneration, neuroinflammation, interictal spikes, neuronal, hyperexcitability, and cognitive decline.

Heterozygous:
No symptoms associated with Lafora disease in heterozygous mice. The disease is inherited in an autosomal recessive manner.
Breeding historyThe mouse line was generated in C57BL/6 genetic background and backcrossed 6 times to C57BL/6.
References
  • Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice.;Burgos Daniel F, Sciaccaluga Miriam, Worby Carolyn A, Zafra-Puerta Luis, Iglesias-Cabeza Nerea, Sánchez-Martín Gema, Prontera Paolo, Costa Cinzia, Serratosa José M, Sánchez Marina P, ;2023;Neurobiology of disease;181;106119; 37059210
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivinghomozygous C57BL/6J males

Literature references

  • Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice.;Burgos Daniel F, Sciaccaluga Miriam, Worby Carolyn A, Zafra-Puerta Luis, Iglesias-Cabeza Nerea, Sánchez-Martín Gema, Prontera Paolo, Costa Cinzia, Serratosa José M, Sánchez Marina P, ;2023;Neurobiology of disease;181;106119; 37059210

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).